Pharming (PHAR) Interest Coverage Ratio (2020 - 2021)
Pharming's (PHAR) quarterly Interest Coverage Ratio came in at 3.01 in Q3 2023, down 146.3% YoY from 6.51 in Q3 2022, and down 146.3% on a QoQ basis from 6.51 in Q3 2022.
Analysis
Pharming (PHAR) Interest Coverage Ratio (2020 - 2021) Analysis & Trends
Pharming (PHAR) has 4 years of Interest Coverage Ratio data on file, last reported at 3.01 in Q3 2023.
- Quarterly Interest Coverage Ratio fell 146.3% year-over-year to 3.01 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was 22.76 (up 92.34% YoY) and the FY2025 annual result came in at 2.67, up 338.29% from the prior year.
- Interest Coverage Ratio eased to 3.01 in Q3 2023, from 6.51 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1027.15 in Q4 2020 to a low of 2447.19 in Q4 2021.
- A 4-year average of 235.9 and a median of 0.56 in 2020 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio plunged 338.25% — and 2022, when it soared 1077.31%.
- Tracing PHAR's Interest Coverage Ratio over 4 years: stood at 1027.15 in 2020, then sank by 338.25% to 2447.19 in 2021, then surged by 100.27% to 6.51 in 2022, then slumped by 146.3% to 3.01 in 2023.
- The last three Interest Coverage Ratio figures came in at 3.01 (Q3 2023), 6.51 (Q3 2022), and 2447.19 (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 1.42 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 10 | Pharming | 794.84 Mn | 635.34 Mn | 141.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 2.79 |
| Mar 31, 2021 | 0.95 |
| Dec 31, 2020 | -2.75 |